| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |